# The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

> **NCT03634436** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 32 (actual)

## Conditions studied

- Hypercholesteremia

## Interventions

- **DRUG:** SHR-1209
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03634436
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-30
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-05-28
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03634436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03634436, "The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03634436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*